Cargando…

The repurposed anthelmintic mebendazole in combination with trametinib suppresses refractory NRAS(Q61K) melanoma

Structure-based drug repositioning in addition to random chemical screening is now a viable route to rapid drug development. Proteochemometric computational methods coupled with kinase assays showed that mebendazole (MBZ) binds and inhibits kinases important in cancer, especially both BRAF(WT) and B...

Descripción completa

Detalles Bibliográficos
Autores principales:	Simbulan-Rosenthal, Cynthia M., Dakshanamurthy, Sivanesan, Gaur, Anirudh, Chen, You-Shin, Fang, Hong-Bin, Abdussamad, Maryam, Zhou, Hengbo, Zapas, John, Calvert, Valerie, Petricoin, Emanuel F., Atkins, Michael B., Byers, Stephen W., Rosenthal, Dean S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Priority Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355037/ https://www.ncbi.nlm.nih.gov/pubmed/28157711 http://dx.doi.org/10.18632/oncotarget.14990

Ejemplares similares

CD133 Is Associated with Increased Melanoma Cell Survival after Multikinase Inhibition
por: Simbulan-Rosenthal, Cynthia M., et al.
Publicado: (2019)

Repositioning of the anthelmintic drug mebendazole for the treatment for colon cancer
por: Nygren, Peter, et al.
Publicado: (2013)

MEK1 is required for the development of NRAS-driven leukemia
por: Nowacka, Joanna D., et al.
Publicado: (2016)

A novel chemo-phenotypic method identifies mixtures of salpn, vitamin D3, and pesticides involved in the development of colorectal and pancreatic cancer
por: Issa, Naiem T., et al.
Publicado: (2022)

Enhanced bioavailability and anthelmintic efficacy of mebendazole in redispersible microparticles with low-substituted hydroxypropylcellulose
por: de la Torre-Iglesias, Paloma Marina, et al.
Publicado: (2014)

BRAF/NRAS wild-type melanoma, NF1 status and sensitivity to trametinib
por: Ranzani, Marco, et al.
Publicado: (2015)

Assessment of Anthelmintic Efficacy of Mebendazole in School Children in Six Countries Where Soil-Transmitted Helminths Are Endemic
por: Levecke, Bruno, et al.
Publicado: (2014)

ES-Screen: A Novel Electrostatics-Driven Method for Drug Discovery Virtual Screening
por: Issa, Naiem T., et al.
Publicado: (2022)

Metformin and trametinib have synergistic effects on cell viability and tumor growth in NRAS mutant cancer
por: Vujic, Igor, et al.
Publicado: (2014)

In Silico and In Vitro Studies for Benzimidazole Anthelmintics Repurposing as VEGFR-2 Antagonists: Novel Mebendazole-Loaded Mixed Micelles with Enhanced Dissolution and Anticancer Activity
por: Elmaaty, Ayman Abo, et al.
Publicado: (2021)

DrugGenEx-Net: a novel computational platform for systems pharmacology and gene expression-based drug repurposing
por: Issa, Naiem T., et al.
Publicado: (2016)

A Phase 2 Clinical Trial of Trametinib and Low-Dose Dabrafenib in Patients with Advanced Pretreated NRAS(Q61R/K/L) Mutant Melanoma (TraMel-WT)
por: Awada, Gil, et al.
Publicado: (2021)

Case report: Complete response of an anaplastic thyroid carcinoma patient with NRAS Q61R/BRAF D594N mutations to the triplet of dabrafenib, trametinib and PD-1 antibody
por: Gui, Lin, et al.
Publicado: (2023)

Response to trametinib in recurrent low-grade serous ovarian cancer with NRAS mutation: A case report
por: Champer, Miriam, et al.
Publicado: (2019)

Targeting GLI by GANT61 involves mechanisms dependent on inhibition of both transcription and DNA licensing
por: Zhang, Ruowen, et al.
Publicado: (2016)

Transcriptome of melanoma cells from two mouse models, Tyr:NRas(Q61K)and Tyr:Rack1-HA, Tyr:NRas(Q61K)
por: Campagne, Cécil, et al.
Publicado: (2017)

Retinoic Acid Mediates Regulation of Network Formation by COUP-TFII and VE-Cadherin Expression by TGFβ Receptor Kinase in Breast Cancer Cells
por: Prahalad, Priya, et al.
Publicado: (2010)

Inorganic polyphosphate in platelet rich plasma accelerates re-epithelialization in vitro and in vivo
por: Carney, Bonnie C., et al.
Publicado: (2020)

Variation of mutant allele frequency in NRAS Q61 mutated melanomas
por: Hélias-Rodzewicz, Zofia, et al.
Publicado: (2017)

Inhibition of the Myocardin-Related Transcription Factor Pathway Increases Efficacy of Trametinib in NRAS-Mutant Melanoma Cell Lines
por: Appleton, Kathryn M., et al.
Publicado: (2021)

Id3 induces an Elk-1–caspase-8-dependent apoptotic pathway in squamous carcinoma cells
por: Chen, You-Shin, et al.
Publicado: (2015)

Anthelmintic mebendazole enhances cisplatin's effect on suppressing cell proliferation and promotes differentiation of head and neck squamous cell carcinoma (HNSCC)
por: Zhang, Fugui, et al.
Publicado: (2017)

Comparison of SARS-CoV-2 RT-PCR on a high-throughput molecular diagnostic platform and the cobas SARS-CoV-2 test for the diagnostic of COVID-19 on various clinical samples
por: Opota, Onya, et al.
Publicado: (2020)

Clonal dominance of CD133(+) subset population as risk factor in tumor progression and disease recurrence of human cutaneous melanoma
por: SHARMA, BHUVNESH K., et al.
Publicado: (2012)

CRISPR-Cas9 Knockdown and Induced Expression of CD133 Reveal Essential Roles in Melanoma Invasion and Metastasis
por: Simbulan-Rosenthal, Cynthia M., et al.
Publicado: (2019)

Multiple Congenital Melanocytic Nevi and Neurocutaneous Melanosis Are Caused by Postzygotic Mutations in Codon 61 of NRAS
por: Kinsler, Veronica A, et al.
Publicado: (2013)

Repurposing Drugs in Oncology (ReDO)—mebendazole as an anti-cancer agent
por: Pantziarka, Pan, et al.
Publicado: (2014)

IntegralVac: A Machine Learning-Based Comprehensive Multivalent Epitope Vaccine Design Method
por: Suri, Sadhana, et al.
Publicado: (2022)

A New Hybrid Neural Network Deep Learning Method for Protein–Ligand Binding Affinity Prediction and De Novo Drug Design
por: Limbu, Sarita, et al.
Publicado: (2022)

Predicting Chemical Carcinogens Using a Hybrid Neural Network Deep Learning Method
por: Limbu, Sarita, et al.
Publicado: (2022)

Predicting Dose-Dependent Carcinogenicity of Chemical Mixtures Using a Novel Hybrid Neural Network Framework and Mathematical Approach
por: Limbu, Sarita, et al.
Publicado: (2023)

Radiofrequency Ablation Remodels the Tumor Microenvironment and Promotes Neutrophil-Mediated Abscopal Immunomodulation in Pancreatic Cancer
por: Faraoni, Erika Y., et al.
Publicado: (2023)

Protein drug target activation homogeneity in the face of intra-tumor heterogeneity: implications for precision medicine
por: Parasido, Erika Maria, et al.
Publicado: (2016)

ROCK inhibitor reduces Myc-induced apoptosis and mediates immortalization of human keratinocytes
por: Dakic, Aleksandra, et al.
Publicado: (2016)

Mebendazole as a Candidate for Drug Repurposing in Oncology: An Extensive Review of Current Literature
por: Guerini, Andrea Emanuele, et al.
Publicado: (2019)

Emerging Perspectives on the Antiparasitic Mebendazole as a Repurposed Drug for the Treatment of Brain Cancers
por: Meco, Daniela, et al.
Publicado: (2023)

BRAF activation by metabolic stress promotes glycolysis sensitizing NRAS(Q61)-mutated melanomas to targeted therapy
por: McGrail, Kimberley, et al.
Publicado: (2022)

P858: FUNCTIONAL STUDIES IN MULTIPLE MYELOMA CELL LINESWITH OVEREXPRESSION OF NRAS Q61R MUTATION
por: Liotti, Romano, et al.
Publicado: (2023)

Functional signaling pathway analysis of lung adenocarcinomas identifies novel therapeutic targets for KRAS mutant tumors
por: Baldelli, Elisa, et al.
Publicado: (2015)

A New Epitope Selection Method: Application to Design a Multi-Valent Epitope Vaccine Targeting HRAS Oncogene in Squamous Cell Carcinoma
por: Savsani, Kush, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_n3ud9b14omse4rrqsggg5nofka